Tardive dyskinesia is primarily treated by psychiatrists and neurologists, often working together. Because TD is caused by medications used to treat mental health conditions, the psychiatrist who prescribed the original medication typically plays a central role. But neurologists, particularly those with specialized training in movement disorders, bring deeper expertise in diagnosing and managing the involuntary movements themselves.
Your Prescribing Psychiatrist
For most people, the first doctor involved in TD care is the psychiatrist who prescribed the antipsychotic or other dopamine-blocking medication that triggered the condition. This makes sense: managing TD requires a careful balance between reducing involuntary movements and keeping the underlying mental health condition stable. Stopping or switching the causative medication is considered the first-line approach when it’s clinically safe to do so, and the prescribing psychiatrist is best positioned to make that call.
Switching from an older (first-generation) antipsychotic to a newer one with lower dopamine-blocking activity, such as clozapine or quetiapine, can sometimes reduce TD symptoms. But this kind of medication change has to be weighed against the risk of destabilizing conditions like schizophrenia or bipolar disorder. Your psychiatrist will know your full medication history and mental health trajectory, which is essential for navigating those trade-offs.
Neurologists and Movement Disorder Specialists
A neurologist may get involved when TD symptoms are moderate to severe, when the diagnosis is uncertain, or when first-line medication adjustments haven’t helped. General neurologists can diagnose and treat TD, but movement disorder specialists offer a distinct advantage. These are neurologists who completed additional fellowship training specifically in movement disorders, giving them more refined skills in distinguishing TD from conditions that can look similar.
That distinction matters more than you might expect. Several other drug-induced movement problems can mimic TD, including drug-induced parkinsonism (which produces a resting tremor, unlike TD’s action-based movements) and akathisia (a feeling of restlessness that, in its tardive form, often appears alongside other involuntary movements like repetitive motions or writhing). A movement disorder specialist is trained to pick apart these overlapping symptoms and arrive at the right diagnosis, which directly affects treatment choices.
The International Parkinson and Movement Disorder Society, a professional organization with more than 12,000 clinicians and researchers, maintains a searchable online directory where you can find a movement disorder specialist near you.
How TD Is Diagnosed
Doctors use a standardized tool called the Abnormal Involuntary Movement Scale (AIMS) to detect and track TD. It’s a 12-item assessment that rates involuntary movements across different body regions on a scale from zero (none) to four (severe). Ideally, the AIMS is administered before starting an antipsychotic so there’s a baseline to compare against.
Current American Psychiatric Association guidelines recommend AIMS screening every six months for patients at high risk of developing TD and every 12 months for others. TD typically develops after about three months on an antipsychotic, though in older adults it can appear in as little as one month. The annual risk of developing TD runs about 6.5% per year for people on older antipsychotics and about 2.6% per year for those on newer ones.
When Coordinated Care Helps Most
The most effective TD management often involves the prescribing psychiatrist and a movement disorder specialist working in coordination. The psychiatrist adjusts or manages the medication driving the patient’s psychiatric condition, while the neurologist focuses on the movement symptoms. This team approach is especially important when TD medications need to be added on top of an existing psychiatric regimen, because drug interactions and overlapping side effects require careful monitoring from both sides.
Primary care clinicians, nurse practitioners, and physician assistants also play a role, particularly in screening. Since TD can develop gradually, the clinician you see most often may be the first to notice early signs, even before you’re aware of them yourself.
FDA-Approved Medications for TD
Two medications were approved in 2017 specifically for tardive dyskinesia. Both work by reducing the amount of dopamine packaged and released in the brain, which helps calm the involuntary movements. They are considered first-line treatments for TD based on strong evidence of benefit with manageable risk.
- Valbenazine (Ingrezza) is taken once daily, starting at 40 mg with a possible increase to 80 mg.
- Deutetrabenazine (Austedo) starts at 6 mg once daily and can be gradually increased up to 48 mg per day, split into two doses.
Either a psychiatrist or neurologist can prescribe these medications. In practice, the choice often depends on which specialist is leading your TD care. Both drugs have been shown to reduce the frequency and severity of involuntary movements, and treatment guidelines from multiple professional organizations support their use as a primary option alongside any feasible changes to the causative medication.
Finding the Right Specialist
If your current doctor hasn’t brought up TD screening or you’re noticing new involuntary movements while taking an antipsychotic, your prescribing psychiatrist is the logical starting point. They can perform an AIMS assessment, adjust medications, and refer you to a movement disorder specialist if needed. If you want to go directly to a specialist, the Movement Disorder Society’s online directory lets you search by location to find neurologists with specific training in these conditions.
Not every area has a nearby movement disorder specialist, but many now offer telemedicine consultations. Since TD diagnosis relies heavily on visual observation of movements, video visits can be a practical alternative to long-distance travel for an in-person appointment.